Previous Article | Next Article ![]()
Infection and Immunity, October 2002, p. 5390-5403, Vol. 70, No. 10
0019-9567/02/$04.00+0 DOI: 10.1128/IAI.70.10.5390-5403.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
The Witebsky Center for Microbial Pathogenesis and Immunology and Department of Microbiology, School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, New York 14214,1 Respiratory Disease Unit, National Animal Disease Center, Ames, Iowa 50010,2 Department of Microbiology, Pathology, and Parasitology, College of Veterinary Medicine, North Carolina State University, Raleigh, North Carolina 276063
Received 17 April 2002/ Returned for modification 7 June 2002/ Accepted 27 June 2002
| ABSTRACT |
|---|
|
|
|---|
| INTRODUCTION |
|---|
|
|
|---|
Heme, a tetrapyrolic molecule which coordinately binds Fe, is a component of many biologically active molecules. Hemoglobin, myoglobin, cytochromes, catalases, and peroxidases all contain heme as a prosthetic group. The biological utility of heme depends upon the propensity of the Fe moiety to alternate between its two oxidation states (Fe2+ and Fe3+). Due to the toxic (i.e., oxidative) nature of heme, the molecule is not allowed to circulate in its free form within the vertebrate host. When heme-containing molecules are degraded, either as a natural process of metabolism or by inadvertent damage, the heme that is released is rapidly bound by molecules such as hemopexin and albumin. Due to the action of these scavenging molecules, the concentration of free heme within the vertebrate host is maintained at exceedingly low levels (39). Nonetheless, the abundance of heme within the cells and tissues of animals provides invading bacteria with a large potential reservoir of nutrient Fe. Pathogenic bacteria, including Bordetella bronchiseptica (4), Bordetella pertussis (4), Escherichia coli (17), Yersinia spp. (45, 54), Neisseria meningitidis (15), Neisseria gonorrhoeae (15), Haemophilus influenzae (46), Vibrio cholerae (53), Corynebacterium diphtheriae (50), and Shigella spp. (28), have been shown to utilize heme as a source of nutrient Fe.
Bordetella avium, a gram-negative bacterium, is the causative agent of coryza (bordetellosis), an avian upper respiratory tract disease which afflicts turkeys and chickens. While this highly infectious disease can be clinically mild, the mortality of infected flocks may be as high as 75% due to secondary infections (51). Symptoms of B. avium infection include anorexia, exudative conjunctivitis, sneezing, and serous discharge from the nares (22). Pathological changes include rhinitis, sinusitis, bronchopneumonia, and, in severe cases, tracheal collapse (22). Coryza exhibits many similarities in disease presentation to whooping cough, an upper respiratory tract infection caused by B. pertussis, an obligate human pathogen. For that reason, B. avium can be utilized as a model system to study the virulence mechanisms of B. pertussis.
We report the identification of an outer membrane protein (OMP), BhuR, which has amino acid sequence homology to bacterial outer membrane heme receptors and whose expression is essential for the utilization of heme and hemoproteins as sources of nutrient Fe by B. avium. In this study, the capacity of B. avium to acquire and utilize heme and hemoproteins as Fe sources is defined. Furthermore, the role of BhuR in heme transport and the importance of the receptor in virulence are firmly established.
| MATERIALS AND METHODS |
|---|
|
|
|---|
was used for all solutions.
|
-32P]dATP-labeled (DuPont New England Nuclear, Boston, Mass.) polynucleotide probe. The filters were hybridized overnight at 65°C in a shaking water bath (Bellco Glass, Inc., Vineland, N.J.). To remove unhybridized probe, the filters were washed two times for 15 min each in 2x SSPE solution (2x SSPE, 0.5% SDS, 5 mM NaPPi) at RT, for 60 min in 0.1x SSPE solution (0.1x SSPE, 0.5% SDS, 5 mM NaPPi) at 65°C, and for 30 min in 0.1x SSPE solution at 65°C. Each filter was exposed overnight at -80°C to Biomar blue-sensitive autoradiographic film (Marsh Biomedical Products Inc., Rochester, N.Y.). The autoradiographs were developed using Kodak developer and fixative solutions (Sigma Biochemicals).
For Southern blot hybridization, DNA fragments were resolved by electrophoresis in a 0.8% agarose gel and stained with ethidium bromide. The DNA was transferred from the agarose gel to a Nytran membrane filter (pore size, 0.2 µm) (Schleicher & Schuell) by a capillary transfer method (35). DNA was irreversibly bound to the filter using a UVC-308 UV cross-linker (Ultra·L
m, Carson, Calif.). After incubation in prehybridization buffer for 1 h at RT, the filters were hybridized overnight at 65°C in a shaking water bath (Bellco Glass, Inc.) with a heat-denatured [
-32P]dATP-labeled polynucleotide probe. Following hybridization, the filters were washed two times for 15 min each time with 2x SSPE solution at RT, for 60 min in 0.1x SSPE solution at 65°C, and for 30 min in 0.1x SSPE solution at 65°C. DNA fragments with homology to the radiolabeled probe were detected by autoradiography, as described above.
Isolation of total B. avium RNA. Total RNA was isolated as previously detailed (6). Briefly, B. avium was cultured to mid-log phase in 12.5 ml of BHI broth containing rifampin (10 µg/ml), EDDHA (100 µM), and hemin (25 µM). Following centrifugation at 16,000 x g for 6 min, the pelleted bacteria were resuspended in 250 µl of 2x lysis buffer (20 mM Tris-HCl [pH 8.0], 20 mM NaCl, 400 µg of proteinase K/ml) and transferred to a chilled microcentrifuge tube containing 300 µl of 10% SDS. Samples were then vortexed, incubated at 37°C for 5 min, and chilled on ice prior to the addition of 300 µl of ice-cold 5 M NaCl. The samples were incubated on ice for 10 min and then centrifuged for 10 min at 16,000 x g. Aliquots (330 µl) were transferred to prechilled microcentrifuge tubes containing 900 µl of ethanol (EtOH). The samples were vortexed and incubated at -80°C for 1 h. Following incubation, the samples were brought to 0°C, and the total nucleic acids were pelleted by centrifugation at 16,000 x g at 4°C for 15 min. The pellets containing RNA and DNA were resuspended in 100 µl of 1 mM EDTA. RNA-DNA solutions were extracted twice with equal volumes of phenol, twice with equal volumes of phenol-chloroform (1:1), and twice with equal volumes of chloroform prior to the addition of 40 µl of 3 M sodium acetate (pH 5.2) and 1 ml of 95% EtOH to precipitate the nucleic acids. Following overnight precipitation at -80°C, the nucleic acid mixture was pelleted by centrifugation at 16,000 x g for 15 min at 4°C. The nucleic acid pellets were washed with ice-cold 75% EtOH, followed by centrifugation at 16,000 x g for 10 min at 4°C. After removal of the EtOH and drying, the nucleic acid pellets were resuspended in 160 µl of water containing 0.05% diethylpyrocarbonate, to which was subsequently added 20 µl of 10x DNase 1 buffer, 132 U of RNasin, and 16 U of DNase 1. The mixture was incubated at 37°C for 20 min prior to the addition of 200 µl of 1 mM EDTA. The reaction mixtures were extracted with an equal volume of phenol-chloroform (1:1), followed by an equal volume of chloroform. One-tenth volume of 3 M sodium acetate (pH 5.2) and 2.5 volumes of 95% EtOH were added to the RNA solutions, and the RNA was precipitated for 1 h at -80°C. After being washed with 75% EtOH, the total RNA was stored at -80°C.
RNase protection assay (RPA). The synthetic oligonucleotide pairs pAD3-35-pAD3-36 (5'-GGA ATT CCG TCT GAG TAC TGC GAT GGC G-3' [the EcoRI site is underlined] and 5'-CCT CTA GAT ATG GTG TGC AGG TGT TGT CGC CC-3' [the XbaI site is underlined]) and pAD3-33-pAD3-34 (5'-CGA ATT CCA TTA TTA GTC GGT AGA CTG GTA TA-3' [the EcoRI site is underlined] and 5'-CCT CTA GAG TAA CCT ATA AAC CCA CTC GGC CTC-3' [the XbaI site is underlined] were designed to be used as primers in a PCR to amplify the 5' terminus of bhuR and the intergenic region between bhuR and bhuS from cosmid p1016, respectively (PCR conditions: denaturation for 45 s at 92°C, annealing for 45 s at 50°C, and extension for 60 s at 72°C for 30 cycles in a Perkin-Elmer [Norwalk, Conn.] DNA Thermal Cycler 480). The amplified products were digested with EcoRI and XbaI prior to ligation into the corresponding endonuclease restriction sites of pBluescript SKII(+) (Stratagene, La Jolla, Calif.). The plasmids were designated pERM29 and pERM30, respectively. Radiolabeled RNA hybridization probes 1 and 2 were produced by in vitro transcription using pERM29 and pERM30 as templates (Ambion [Austin, Tex.] T3 MAXIscript transcription kit), respectively.
RPAs were performed using a Hybspeed RPA kit (Ambion) following the vendor's guidelines. Protected fragments were visualized using a PhosphorImager (Bio-Rad, Hercules, Calif.).
Outer membrane isolation. A modification of the protocol of Leyh and Griffith (31) was used to purify B. avium outer membranes. Briefly, B. avium was cultured at 37°C to stationary phase in 250 ml of BHI broth containing either 100 µM EDDHA (Fe stressed) or 36 µM FeSO4 (Fe replete). The cells were pelleted by centrifugation at 3,000 x g for 20 min at 4°C and resuspended in 15 ml of ice-cold HEPES buffer (10 mM HEPES [pH 7.4] containing 0.1 mM phenylmethylsulfonyl fluoride). The cells were frozen at -80°C overnight, thawed in an ice bath, and immediately stored on ice. Cells packed in ice were sonicated three time for 2 min each using a microtip and a Sonifier 450 ultrasonicator (Branson Ultrasonics Corp., Danbury, Conn.) at a setting of 6 and at a 50% cycle. The sonicate was centrifuged at 3,000 x g for 20 min at 4°C to remove unbroken cells. Total membranes were obtained from the clarified supernatant by centrifugation at 100,000 x g for 60 min at 4°C. Total membranes were resuspended in 2 ml of extraction buffer (1% N-lauroyl-sarcosine in 10 mM HEPES [pH 7.4]) by gentle agitation at RT for 60 min. The insoluble outer membranes were pelleted by centrifugation at 100,000 x g for 60 min at 4°C. The extraction was repeated to remove residual amounts of contaminating cytoplasmic proteins. The OMPs were resuspended in 200 µl of deionized water and stored at -80°C. The total protein concentration of the OMP suspensions was determined with the Bio-Rad protein assay using bovine serum albumin as the standard.
SDS-PAGE analysis of OMPs. OMPs were resolved by SDS-polyacrylamide gel electrophoresis (PAGE) (27). For each sample, 8 µg of total OMPs was solubilized by being boiled for 10 min in loading buffer (31 mM Tris [pH 6.8]-2% SDS-2.5% 2-mercaptoethanol-10% glycerol). The solubilized proteins were resolved in 7.5% polyacrylamide gels and visualized by staining them with colloidal Coomassie brilliant blue (40).
Cloning and sequencing of bhuR.
The bhuR gene was initially identified by characterizing the insertion site of TnphoA in Pho20. TnphoA contains a unique SalI site which is located asymmetrically to the kanamycin-resistance gene of the transposon. To clone the SalI fragment comprising the fusion joint and flanking regions of the transposon insertion of Pho20, chromosomal DNA of the mutant was digested with SalI. The resulting restriction fragments were ligated into the SalI site of pBluescript KS(+). The ligated plasmids were transformed by osmotic shock into E. coli DH5
F'tet (Life Technologies, Inc.), and transformants were selected for the ability to grow in the presence of kanamycin. One kanamycin-resistant transformant was chosen for further study. The plasmid in this transformant, which contained a 12-kbp SalI insert of B. avium chromosomal DNA, was designated pAD3. The 12-kbp insert of pAD3 was comprised of the leftmost portion of TnphoA, including the Kanr cassette, the phoA gene, the transposon insertion site, and 7.4 kbp of Pho20 chromosomal DNA (data not shown).
A partial sequence of the insertionally mutated gene of Pho20 was obtained by sequencing from the point of the transposon insertion into the B. avium chromosomal DNA of Pho20 in pAD3. A synthetic oligonucleotide homologous to TnphoA (Tnphoterm: 5'-CTG AGC AGC CCG GTT TT-3') was used to prime a sequencing reaction of pAD3. Using that partial sequence, the synthetic oligonucleotides pAD3-2 (5'-CGTGCGCGGTTCCGA-3') and pAD3-3 (5'-GGCCGAAGCGGTGGC-3') were engineered for use as primers in PCR to amplify a 358-bp fragment from pAD3 which was homologous to the chromosomal sequences located 5' to the transposon fusion joint (PCR conditions: denaturation for 30 s at 92°C, annealing for 45 s at 51°C, and extension for 60 s at 72°C for 30 cycles in a Perkin-Elmer DNA Thermal Cycler 480). The 358-bp fragment was radiolabeled with [
32-P]ATP by random priming (Random Primers DNA-labeling system; Life Technologies) and used as a colony blot hybridization probe to screen by colony blot hybridization a cosmid-based B. avium genomic library for clones containing a cosmid with homology to the insertionally mutated gene of Pho20. A single colony, containing a cosmid designated p1016, was chosen for further study.
To subclone the region containing homology to the insertionally mutated gene of Pho20, p1016 was digested with EcoRI and the restriction fragments were ligated into the EcoRI site of pMECA (61). The ligation reaction was transformed by osmotic shock into E. coli strain DH5
F'tet, and transformants were selected for the ability to grow in the presence of ampicillin. The transformants were screened by colony blot hybridization for homology to the 358-bp radiolabeled hybridization probe to identify a single clone containing a plasmid designated pERM1.
Sequence walking was performed to sequence the insert of pERM1, beginning at the point identified to be the site of the transposon insertion in Pho20 and continuing in a 5' direction. After a partial open reading frame (ORF) had been identified, the remaining 972 bp of the ORF were obtained by sequencing the insert of p1016.
To isolate the bhuR gene for cloning, p1016 was digested with XhoI and EcoRV. The nucleotide fragments were directionally cloned into pBluescript KS(+) and transformed into E. coli strain DH5
F'tet. Transformants selected for the ability to grow in the presence of ampicillin were screened by colony blot hybridization for homology to bhuR using the bhuR-specific 358-bp radiolabeled hybridization probe. Plasmid pERM23, containing a 2.7-kbp insert comprising the entire 2,565-bp ORF of wild-type (wt) B. avium bhuR, 120 bp of 5' flanking DNA, and 67 bp of DNA flanking the 3' terminus of the gene, was obtained. pERM25 was engineered by ligating a KpnI/SstI fragment of pERM23, which included the bhuR ORF, into the corresponding restriction sites of the broad-host-range vector pRK415 (24). Insertion of the KpnI/SstI DNA fragment into pRK415 placed the bhuR gene under the control of the vector's lac promoter.
Cloning the rhuIR/bhuRSTUV locus. Sequence analysis revealed that the insert of cosmid p1016 included six of the seven predicted genes of the heme uptake locus (63) (i.e., rhuIR and bhuRSTU, but not bhuV). To obtain a cosmid clone which included the complete locus, a 309-bp nucleotide hybridization probe homologous to the 5' terminus of bhuS, which was obtained by EcoRV digestion of p1016, was used in a colony blot hybridization to screen a cosmid-based B. avium genomic library for a cosmid clone with homology to bhuS. The 30-kbp insert of the bhuS-positive cosmid p31 was confirmed by sequence analysis to include all seven genes of the uptake locus. An 11-kbp DNA fragment containing the locus, isolated by digestion of p31 with BglII and SalI endonucleases, was ligated into the BamHI and SalI sites of pBluescript KS(+) to produce pERM32. For subsequent expression experiments in B. avium, the 11-kbp SalI/SmaI insert was removed from pERM32 and ligated into pUFR047 (13) at the XbaI (blunted by use of the Klenow fragment of DNA polymerase) and SalI sites. The pUFR047-based plasmid including the heme uptake locus was designated pERM33.
Engineering a chromosomal nonpolar bhuR mutation in 4169rif.
A nonpolar mutation of the bhuR gene of B. avium was introduced by allelic exchange into the chromosome of 4169rif, a spontaneous rifampin-resistant mutant of 4169. In brief, a 1.7-kbp truncated copy of bhuR was amplified by PCR from B. avium 4169rif chromosomal DNA using a synthetic oligonucleotide primer homologous to the 5' terminus of the bhuR ORF (pAD3-11; 5'-TTGGATCCTCATCGATAAAAC-3' [the BamHI site is underlined]) and a second oligonucleotide primer homologous to internal sequence of the bhuR ORF (pAD3-13; 5'-GACTGCAGGTGAATTCATCCTGGC-3' [the PstI site is underlined]) (PCR conditions: denaturation for 30 s at 92°C, annealing for 45 s at 44°C, and extension for 2 min 15 s at 72°C for 30 cycles). The amplified DNA fragment including the truncated bhuR gene was directionally cloned into pBluescript KS(+) to create pERM11. A nonpolar kanamycin resistance cassette obtained from Tn5 (T. D. Connell, unpublished data) was ligated into a unique EcoNI site located within the bhuR gene fragment of pERM11 to produce pERM11.1. The DNA fragment of pERM11.1 containing bhuR::kan that was isolated by digestion of the plasmid with BamHI and EcoRI was subsequently directionally cloned into pCVD442, a sacB-based positive-selection suicide vector (14), to produce pERM16. Allelic exchange to replace the wt bhuR with the mutant bhuR::kan allele in 4169rif was performed using a two-step process. In the initial step, pERM16 was mobilized by conjugation into 4169rif using E. coli SM10
pir (Life Technologies, Inc.) as the helper strain (35). Cointegrates were selected for the ability to grow on medium containing ampicillin. Due to the substantial number of false positives produced by the high rate of spontaneous ampicillin resistance, a screening method was employed to identify a positive clone. Colony blot hybridizations of 1,500 first-stage cointegrates were screened for the presence of the kanamycin cassette of pERM16 using the radiolabeled Tn5-derived Kanr cassette as a hybridization probe. The cointegrates were analyzed by Southern hybridization to ensure that pERM16 had integrated properly into the bhuR locus of 4169rif (data not shown). One cointegrate with the proper hybridization pattern was cultured to stationary phase in BHI broth supplemented with rifampin. One milliliter of the stationary-phase culture was inoculated onto BHI agar supplemented with rifampin and 20% sucrose. Of the 92 colonies which grew in the presence of 20% sucrose, 89 were sensitive to ampicillin, an indication of the loss of the vector sequences. One clone, designated 4169rif(bhuR::kan), in which the wt bhuR gene had been replaced with the bhuR::kan allele, was chosen for further study.
Complementation of bhuR mutants.
pRK415- and pUFR047-based recombinants were mobilized into B. avium by conjugation using E. coli SM10
pir as a helper strain. Strains containing only pRK415 or pUFR047 were used as negative controls in all complementation growth assays.
Growth assays. Initial growth assays in broth cultures were performed using 300-ml acid-washed sidearm flasks (Bellco Glass, Inc.) containing 50 ml of BHI broth. The cultures were inoculated with 500 µl of Fe-stressed BHI(100 µM EDDHA) bacterial cultures which had been cultured to an optical density at 600 nm (OD600) of 1.0 (DU 640B spectrophotometer; Beckman Instruments Inc., Fullerton, Calif.). The cultures were supplemented, as appropriate, with an Fe source or with an Fe chelator. All cultures were incubated at 37°C in an Innova 4330 incubator shaker (New Brunswick Scientific, Edison, N.J.). The cell densities of the cultures at various time points were determined using a Klett-Summerson photoelectric colorimeter (Klett Manufacturing Co., Inc, New York, N.Y.). Other broth culture growth assays and complementation growth assays were performed using 15-ml sterile culture tubes (Laboratory Products Sales, Rochester, N.Y.) containing 3 ml of BHI broth. Each culture was inoculated with 30 µl of an Fe-stressed [BHI(100 µM EDDHA)] seed culture which had been cultured to an OD600 of 1.0 (Beckman DU 640B spectrophotometer). At various time points, 100 µl of each sample was diluted with 100 µl of the appropriate medium within the wells of a 96-well ELISA plate, and the OD600 of the culture was determined using a Titertek Multiskan Plus enzyme-linked immunosorbent assay plate reader (ICN, Irvine, Calif.). In the initial hemin utilization assays, hemin was added to the culture at a final concentration of between 5 and 50 µM. While no growth difference was observed, a concentration of 5 µM hemin was chosen for all subsequent growth experiments.
Engineering a hemA mutation in B. avium.
A cosmid-based genomic library of B. avium 4169, packaged into lambda phage heads using a GigapakII kit (Stratagene) (Connell, unpublished), was transfected into E. coli RK1065nal, a spontaneous nalidixic acid-resistant hemA mutant of E. coli RK1065 (37) which requires supplementation of culture medium with the heme precursor
-aminolevulinic acid (ALA) for growth. Transfectants expressing hemA were selected by growth on Luria-Bertani agar in the absence of ALA. Of the six positive transfectants, clone pL1 was chosen for further study. A 2-kbp EcoRI fragment of pL1 which included hemA was ligated into the EcoRI recognition site of pBluescript KS(+) to produce pERM34. To confirm that the plasmid conferred a hemA phenotype, pERM34 was transformed into E. coli RK1065 and the recombinants were tested for growth in the absence of ALA.
Gene splicing by overlapping ends (23) was used to engineer a mutant hemA gene for ligation into the suicide vector pCVD442tet, a derivative of pCVD442 (14). pCVD442tet contains a tetracycline resistance cassette cloned into the SmaI site of pCVD442. Using plasmid pERM34 as a template, 450 bp of DNA located 5' of the ATG start codon and 500 bp of the 3' terminus and downstream DNA of B. avium hemA were amplified by PCR. For that purpose, the synthetic oligonucleotide primer pairs hemA-6-hemA-5 and hemA-4-hemA-3 were used, respectively (hemA-3, 5'-CCG AGC TCG TCG ACG GTA TAC GAT AAG CT-3' [the SacI site is underlined]; hemA-4, 5'-AGC GTT TCC CTA CTC CTG CAG GCT GAG GCC ATT ATT GAA AC-3'; hemA-5, 5'-CAG GAG TAG GGA AAC GCT G-3'; and hemA-6, 5'-GTG AGC TCC GCT CTA GAA CTA GTG GAT CAG-3' [the SacI site is underlined]). The PCR conditions were as follows: denaturation for 45 s at 95°C, annealing for 45 s at 42°C, and extension for 1 min at 72°C for 30 cycles. Each PCR product was purified and mixed together, and the mixture was used as the template in PCR using the oligonucleotides hemA-6 and hemA-3 as primers for a secondary round of DNA amplification (gene splicing by overlapping ends). To produce pERM34, a 1.0-kbp final product, consisting of 500 bp of 5' flanking DNA to the ATG start codon of hemA, the 3'-terminal 162 bp of the gene, and 162 bp of downstream flanking DNA, was digested with SacI endonuclease, and the fragment was ligated into the unique SacI site of pCVD442tet. pERM36 was mobilized into 4169rif and 4169rif(bhuR::kan) by conjugation as described above (35). Selection of primary cointegrates was accomplished by plating the transconjugates onto BHI agar containing tetracycline (10 µg/ml). Southern hybridizations confirmed that pERM36 had properly integrated into the hemA locus of both 4169rif and 4169rif(bhuR::kan) (data not shown). One cointegrate from each strain with the proper hybridization pattern was cultured to stationary phase in BHI broth supplemented with rifampin. Bacteria were inoculated onto BHI agar supplemented with 20% sucrose and 60 sucrose-resistant colonies from each strain were screened by colony blot hybridization for the loss of the 5' region of hemA (data not shown). One potential hemA mutant clone from each initial B. avium strain was further characterized by Southern blot hybridization to confirm that wt hemA had been replaced by the mutant hemA allele (data not shown). These hemA mutants were designated 4169rifhemA and 4169rif(bhuR::kan)hemA, respectively.
B. avium virulence studies. The virulence of wt and mutant B. avium strains was determined using both direct-challenge and competitive-infection assays.
In the direct-challenge infection, cultures of 4169rif and Pho20 were grown in BHI broth supplemented with the metal chelator EDDHA (100 µM) and with 200 µg of streptomycin/ml. Overnight cultures of the bacteria were diluted to 109 CFU/ml. Serial dilutions of B. avium cultures were plated on blood agar plates containing streptomycin on the day of challenge to confirm the inoculum size. Two-day-old turkey poults (n = 30 per experimental group) were challenged with 104 CFU (0.1 ml at 105 CFU/ml) of bacteria per inoculum by droplet instillation in the right nare. After challenge, the poults were observed daily during a 2-week experimental period and scored for clinical signs of coryza.
For the competition infection, cultures of 4169rif and Pho20 were grown as described above. Two-day-old turkey poults were challenged with a mixture of 104 CFU of 4169rif and 104 CFU of Pho20 by instillation into the right nare (0.1 ml per instillation; n = 10 poults per experiment). After euthanasia on day 14, tracheal tissue samples isolated from each poult were weighed and homogenized. Serial 10-fold dilutions of tracheal homogenates were cultured on blood agar plates containing rifampin (10 µM) and streptomycin (200 µM) to select for total B. avium (4169rif plus Pho20) and on blood plates containing rifampin, streptomycin, and kanamycin (50 µM) to select solely for Pho20. The numbers of recovered bacteria were determined by use of a colony counter (MiniCount; Imaging Products International, Simi Valley, Calif.). The number of wt bacteria was calculated by subtracting the number of Pho20 CFU from the total number of CFU. The relative numbers of wt and mutant B. avium CFU were reported as percentages of total B. avium CFU. The percentage for each strain was calculated by calculating the ratio of either wt or mutant CFU isolated to the total number of B. avium CFU isolated and multiplying the value by 100.
Nucleotide sequencing. Nucleotide sequencing was performed by the CAMBI Nucleotide Sequencing Facility at The University at Buffalo, State University of New York, and by the Biopolymer Facility at Roswell Park Cancer Institute, Buffalo, N.Y.
Nucleotide sequence accession number. The nucleotide sequence of the rhuIR/bhuRSTUV locus was assigned GenBank accession number AY095952.
| RESULTS |
|---|
|
|
|---|
400 Klett units). These results demonstrated that 4169rif has the potential to utilize hemin as a sole source of Fe for growth.
|
Cloning the B. avium heme receptor gene. To identify the gene of Pho20 into which the transposon had been inserted and to provide genetic tools to clone the wt gene, the fragment of the Pho20 chromosome containing the transposon was cloned and sequenced. Sequencing of the wt gene revealed a 2,565-bp ORF, designated bhuR (for Bordetella heme utilization), which had a coding capacity for a predicted polypeptide of 93 kDa with significant amino acid sequence similarity to bacterial outer membrane heme receptor proteins, including BhuR of B. pertussis (63), PfhR of Pseudomonas fluorescens (44), PhuR of Pseudomonas aeruginosa (43), HupA of Vibrio vulnificus (33), HmbR of N. meningitidis (56), and HutA of V. cholerae (20) (Table 2). A typical signal peptide and an Ala-X-Ala cleavage site at amino acid positions 20 to 22 are evident in the polypeptide sequence, which would be expected for a protein destined for transport to the outer membrane. The projected cleavage of the signal peptide would produce a mature polypeptide of 91 kDa.
|
FRAP and NPNL motifs are also conserved among bacterial outer membrane heme receptors (2). Amino acid sequences consistent with a FRAP box (YRAP) were distinguished between amino acids 604 and 607 of BhuR, while an amino acid sequence with homology to an NPNL motif (NPNLKPETSKGWE) was identified between amino acid positions 627 and 639. Unlike other bacterial outer membrane heme receptors, a conserved histidine which is commonly found between the FRAP and NPNL domains was absent in the BhuR amino acid sequence. Rather, a tyrosine (Tyr-616) occupied the position usually held by the histidine. Since tyrosine and histidine have similar biological properties, it is conceivable that the tyrosine at amino acid position 616 is a conservative substitution for heme utilization. Furthermore, BhuR contains a tyrosine residue at the extreme C terminus. The presence of a hydrophobic aromatic residue is highly conserved among proteins which form a ß-barrel within the bacterial outer membrane (58).
A unique feature of BhuR in comparison to other bacterial heme receptors is the presence of an extension of 36 amino acids at the N terminus of the protein. While this portion of the protein has no homology to other bacterial heme receptors, with the exception of the closely related heme receptor protein of B. pertussis (63), the region does have homology to the N terminus of FecA, an outer membrane siderophore receptor of E. coli (64). It has been established that the N-terminal domain of FecA interacts in a manner to promote siderophore-dependent regulatory activity of the fec operon (25). It is feasible that a similar heme-dependent regulatory role in the controlled expression of the bhu operon may be inherent in the N-terminal extension of BhuR (26).
bhuR resides in a heme utilization locus. Sequence analysis of DNA flanking bhuR revealed that the gene resides within a heme utilization locus comprising seven cistrons. Genes located downstream of bhuR encode proteins with amino acid homology to a putative heme degradase (bhuS), a periplasmic binding protein (bhuT), a permease (bhuU), and an ATPase (bhuV). Located immediately upstream of bhuR are rhuI and rhuR, two ORFs which encode proteins with homology to FecI and FecR of E. coli (26). RhuI, an extracytoplasmic-function sigma factor, and RhuR, a sigma factor regulator, have been shown to regulate the expression of bhuR in response to the local concentrations of both heme and Fe (26). A locus with similar genetic structure has been reported in B. pertussis (63). An inspection of the arrangement of the genes in the bhu locus indicated that the genes likely reside in a polycistronic operon. Consensus promoter sequences were identified in the DNA located immediately 5' of rhuIR and in the intergenic region between rhuR and bhuR. Promoter sequences were not evident elsewhere in the locus. A schematic of the B. avium heme utilization locus is depicted in Fig. 2.
|
|
|
|
Utilization of heme and hemoproteins by B. avium requires bhuR expression. While bhuR has been shown to have homology to heme receptors and Pho20 has been demonstrated to lack the ability to grow with hemin as the sole source of Fe, the importance of bhuR in heme uptake had not been confirmed using the defined mutant 4169rif(bhuR::kan). To determine if expression of bhuR is required for the utilization of hemin as an Fe source by B. avium, the growth of 4169rif (pUFR047) was compared to the growth of 4169rif(bhuR::kan) and to the growth of 4169rif(bhuR::kan) after the introduction of pERM33, a pURF047-derived plasmid encoding the complete rhu/bhu locus of B. avium. When cultured in BHI broth, 4169rif(pUFR047), 4169rif(bhuR::kan)(pURF047), and 4169rif(bhuR::kan)(pERM33) exhibited equivalent growth (Fig. 5A). Supplementation of BHI broth with the Fe chelator EDDHA at 300 µM [BHI(EDDHA)] inhibited the growth of all three strains (Fig. 5B). Supplementation of BHI(EDDHA) broth with hemin rescued the growth of 4169rif(pURF047) but did not restore the growth of 4169rif(bhuR::kan)(pUFR047). In contrast, when BHI(EDDHA) was supplemented with hemin, the culture densities of 4169rif(bhuR::kan)(pERM33) were equivalent to that of 4169rif(pUFR047) (Fig. 5C). These data are consistent with the model that expression of bhuR is essential for the utilization of hemin as a sole source of Fe by B. avium.
Heme is rarely found in its free form in the body. Rather, the molecule is usually coordinately bound to proteins such as hemoglobin, myoglobin, and catalase. To determine whether B. avium has the capacity to utilize hemoproteins as sources of nutrient Fe, 4169rif and 4169rif(bhuR::kan) were compared in an end point growth assay (8) in which the culture medium had been supplemented with either hemin or a hemoprotein. The relative growth potential of each strain was determined by measuring the OD600 of individual stationary-phase cultures (Fig. 6). At 300 µM, EDDHA inhibits growth of both 4169rif and 4169rif(bhuR::kan) (Fig. 6, Control). To ensure that the lack of growth observed in BHI(EDDHA) was due to the chelation of Fe, the chelated broth was supplemented with FeSO4 (Fig. 6, Fe). Under these conditions, 4169rif and 4169rif(bhuR::kan) displayed equivalent growth. Supplementation of BHI(EDDHA) with either hemin (Fig. 6, Hemin), human hemoglobin (Fig. 6, hHb), turkey hemoglobin (Fig. 6, tHb), myoglobin (Fig. 6, Myo), or catalase (Fig. 6, Cat) supported significantly less growth of mutant 4169rif(bhuR::kan) than of 4169rif. These data support the conclusion that expression of bhuR is essential for the utilization of heme and, furthermore, establish that efficient acquisition of Fe from hemoproteins requires expression of bhuR.
|
|
As a more sensitive means to evaluate survival of the organism in vivo, birds were also infected with mixtures of wt and mutant strains in a competitive-challenge model. In this model, turkey poults were simultaneously challenged intranasally with equal mixtures of 4169rif and Pho20 (104 CFU each). After 14 days, 90.15% (±19.8 standard deviation from the mean) of B. avium cells recovered from the tracheas of infected poults were the wt strain. Only 9.95% (±19.8; statistical difference [P < 0.05] from the percentage of the total obtained for 4169rif; Student's t test) of the total B. avium cells recovered from the infected birds were the bhuR mutant. These data strongly indicated that the bhuR mutant is competitively inferior to its wt parent in its capacity to colonize the tracheas of poults.
| DISCUSSION |
|---|
|
|
|---|
The molecular mechanism by which heme receptors translocate heme-bound Fe into the cell has not been elucidated to any great degree. A common trend, however, is that heme receptors are present in the outer membranes of gram-negative bacteria as a single polypeptide moiety. In contrast, BhuR may exist in two forms on the surface of B. avium. The outer membranes of Fe-stressed B. avium cells harbor two forms of BhuR: a 91-kDa form and an 82-kDa form. A striking difference between the two forms of the protein is that the smaller form lacks a 36-amino-acid N-terminal extension which is present in the 91-kDa form. Notably, this 36-amino-acid segment is absent from the amino acid sequences of other bacterial heme receptors. The segment does, however, have amino acid homology with the N terminus of FecA, an outer membrane ferric citrate receptor of E. coli (64). In a manner similar to that of the expression of bhuR (26), expression of fecA is controlled by an extracytoplasmic-function sigma factor (FecI) and an anti-sigma factor (FecR) which respond simultaneously to the local concentrations of Fe and ferric citrate, the specific receptor ligand of FecA (25, 43, 48). To respond to the presence of ferric citrate in the local environment, the N terminus of FecA must interact with some component of the FecI-FecR signal cascade. When ferric citrate is detected by the FecA-FecI-FecR complex, expression of the polycistronic FecABCDE locus is enhanced (25). It is provocative to speculate that the 36-amino-acid segment of BhuR has a role in BhuR-RhuI-RhuR-dependent, heme-induced expression of the bhu locus (bhuRSTUV). Experiments to evaluate this regulatory model are being vigorously pursued (T. D. Connell and A. Kirby, unpublished results).
In contrast to the unelucidated function of the N-terminal extension, BhuR harbors other conserved motifs whose potential biological functions are discernible from structural comparisons to other bacterial heme receptors. Two structural motifs that are conserved among proteins which functionally interact with TonB, an energy transducer and common component of Fe uptake machinery in bacterial cells (3), are also conserved in BhuR. The acquisition and utilization of heme as a source of nutrient Fe has been shown to be a TonB-dependent process in various bacteria (1, 16, 37, 42, 47, 54, 60, 62). The presence of two conserved TonB motifs within BhuR, in combination with the observation that TonB is required for heme utilization by B. pertussis (41, 47), suggests that a functional interaction between BhuR and TonB may be necessary for the operation of the bhu-encoded heme utilization system. This hypothesis is further strengthened by the observation that introduction of the genes encoding BhuR or the genes constituting the entire locus (bhuRSTUV) did not complement RK1065, a tonB-proficient hemA mutant of E. coli (37) (data not shown). Failure of bhuR or the bhuRSTUV locus to confer heme uptake upon RK1065 may be explained by the inability of the B. avium heme uptake system to interact in a productive manner with the TonB system of E. coli. Other studies confirmed that heterologous combinations of tonB genes and genes encoding Fe uptake systems from different species are often dysfunctional (20). Experiments are ongoing to engineer a tonB mutant of B. avium to directly evaluate the functional dependence of BhuR on TonB.
Although bhuR is essential for efficient utilization of heme and hemoproteins as sole sources of Fe by B. avium, growth experiments confirmed that disruption of the gene in Pho20 and in 4169rif(bhuR::kan) did not totally abrogate heme utilization (Fig. 1D and 5C). Several bacterial pathogens, including H. influenzae (9, 10, 18, 38), N. meningitidis (30, 57), P. aeruginosa (29, 43, 44), and V. cholerae (20, 36), have been shown to express multiple heme utilization systems. It is likely that the residual growth observed for Pho20 and 4169rif(bhuR::kan) in culture medium containing hemin as the sole Fe source is promoted by expression of a secondary, albeit lower-affinity, heme utilization system.
Due to potent toxicity caused by its oxidative potential, accumulation of unsequestered heme within a cell is lethal. Cells, therefore, have evolved methods to inhibit inordinate uptake of heme. For example, genes encoding heme acquisition proteins are coordinately regulated to prevent the lethal accumulation of heme. Disruption in the stoichiometric levels of expression of a gene within a bacterial heme utilization regulon has been demonstrated to have dire effects on cell survival (21, 55). The introduction of pERM25, a multicopy expression plasmid encoding recombinant BhuR, into 4169rif(bhuR::kan) was correlated with a decreased rate of growth of the cell in culture medium in which heme was the sole source of available Fe (data not shown). In contrast, normal growth was reestablished for 4169rif(bhuR::kan) when a plasmid containing the entire rhuIR-bhuRSTUV locus was introduced into the mutant (Fig. 5C). These results supported the model that stoichiometric expression of all seven bhu genes is necessary to avoid heme toxicity of the cell. Supporting data was obtained when p2025 was obtained from compensatory mutants which arose in the culture. p2025 harbors a spontaneous mutation within the vector sequences of pERM25. Compared to the level of expression of BhuR in 4169rif(bhuR::kan)(pERM25), expression of the heme receptor was dramatically less in 4169rif(bhuR::kan)(p2025). Yet, in contrast to 4169rif(bhuR::kan)(pERM25), the growth rate of 4169rif(bhuR::kan)(p2025) in heme-containing culture medium was closer to that observed for 4169rif, the wt parent (data not shown). A similar pattern of expression and growth inhibition (e.g., toxicity) was reported for B. pertussis when a chromosomal bhuR mutant was complemented with a recombinant plasmid expressing only bhuR (63); the bhuR mutant of B. pertussis could be complemented only by the introduction of a plasmid containing the entire bhuRSTUV locus. In that study, the authors proposed that the failure to complement the mutant with a recombinant bhuR plasmid was due to polar effects of the chromosomal bhuR mutation that altered the expression of downstream bhuSTUV genes (63). In the case of B. avium, RNase protection experiments demonstrated that polar effects on downstream genes were not significant in either Pho20 or 4169(bhuR::kan). Without similar analysis of the expression of the downstream genes in the bhuR mutants of B. pertussis, it cannot be ascertained whether the inability to complement with recombinant bhuR can be attributed to polar effects. From the data obtained in this study, it is more likely that the failure to complement the bhuR mutant of B. pertussis with bhuR was the result of lethal events caused by excessive uptake of heme in the absence of adequate levels of "detoxifying" components encoded by the accessory genes in the locus.
Several bacterial outer membrane heme receptors have been shown to directly bind heme and/or hemoglobin (12, 37, 42, 57, 65, 67). While a physical interaction between B. avium BhuR and heme (or hemoglobin) could not be demonstrated in this study, the experiments reported here using the hemA mutant provide strong evidence that BhuR is essential for the transport of heme into the bacterial cell. The inability to demonstrate heme binding to BhuR in vitro may indicate that the binding affinity for the molecule is low or that the conditions used for binding were inadequate. It is intuitive that there is at least some transient interaction of heme with BhuR. The present model, based on the hemA data, the comparative homology of BhuR to other heme receptors, and the outer membrane localization of the protein, is that BhuR binds extracellular heme prior to initiating transport of the molecule into the cytoplasm of the cell.
The ability to acquire Fe from the host is considered to be an important virulence determinant for most bacterial pathogens (66). This belief has been substantiated in a variety of bacteria, including Streptococcus pneumoniae (59), V. cholerae (19), N. meningitidis (56), and E. coli (62). In like manner, heme uptake systems in B. avium appear to be a factor contributing to virulence. Inactivation of the bhuR gene was correlated with a reduced ability of the mutant strain to compete with its wt parent for colonization of the trachea during infection. Nevertheless, inactivation of bhuR did not absolutely abrogate virulence in B. avium. These data suggest that the Bhu system is not the sole means by which B. avium acquires heme during infection. It is apparent that for many bacterial pathogens the need to acquire heme during infection must be an inordinately strong selective pressure. Other bacterial pathogens encode multiple heme uptake systems (9, 10, 18, 20, 29, 30, 36, 38, 43, 44, 57), which is likely a reflection of the importance of heme uptake in their life cycles. Thus, it is not unreasonable to hypothesize that B. avium encodes a second heme utilization system for acquisition of heme in the absence of BhuR and that deletion of both systems may be required before virulence is totally abrogated.
A gene whose product has amino acid homology to BhuR has been identified in B. pertussis and in B. bronchiseptica (63). The high degree of conservation throughout the pathogenic members of the Bordetellae suggests an essential role for bhuR in survival and pathogenesis.
| ACKNOWLEDGMENTS |
|---|
This work was supported by funds made available to E.R.M. by training grant AI07614-01 from the National Institutes of Health; by funds made available to T.D.C. by the School of Medicine and Biomedical Sciences at the University at Buffalo, State University of New York; and by funds made available to P.E.O. and R.E.S. by the U.S. Department of Agriculture.
| FOOTNOTES |
|---|
| REFERENCES |
|---|
|
|
|---|
| 1. | Biswas, G. D., J. E. Anderson, and P. F. Sparling. 1997. Cloning and functional characterization of Neisseria gonorrhoeae tonB, exbB and exbD genes. Mol. Microbiol. 24:169-179.[CrossRef][Medline] |
| 2. | Bracken, C. S., M. T. Baer, A. Abdur-Rashid, W. Helms, and I. Stojiljkovic. 1999. Use of heme-protein complexes by the Yersinia enterocolitica HemR receptor: histidine residues are essential for receptor function. J. Bacteriol. 181:6063-6072. |
| 3. | Braun, V. 1995. Energy-coupled transport and signal transduction through the gram-negative outer membrane via TonB-ExbB-ExbD-dependent receptor proteins. FEMS Microbiol. Rev. 16:295-307.[CrossRef][Medline] |
| 4. | Brickman, T. J., and S. K. Armstrong. 1999. Essential role of the iron-regulated outer membrane receptor FauA in alcaligin siderophore-mediated iron uptake in Bordetella species. J. Bacteriol. 181:5958-5966. |
| 5. | Bullen, J. J., H. J. Rogers, and E. Griffiths. 1978. Role of iron in bacterial infection. Curr. Top. Microbiol. Immunol. 80:1-35.[Medline] |
| 6. | Chauhan, S., D. E. Titus, and M. R. O'Brian. 1997. Metals control activity and expression of the heme biosynthesis enzyme delta-aminolevulinic acid dehydratase in Bradyrhizobium japonicum. J. Bacteriol. 179:5516-5520. |
| 7. | Connell, T. D., A. J. Martone, and R. K. Holmes. 1995. A new mobilizable cosmid vector for use in Vibrio cholerae and other gram-negative bacteria. Gene 153:85-87.[CrossRef][Medline] |
| 8. | Connell, T. D., A. Dickenson, A. J. Martone, K. T. Militello, M. J. Filiatraut, M. L. Hayman, and J. Pitula. 1998. Iron starvation of Bordetella avium stimulates expression of five outer membrane proteins and regulates a gene involved in acquiring iron from serum. Infect. Immun. 66:3597-3605. |
| 9. | Cope, L. D., R. Yogev, U. Muller-Eberhard, and E. J. Hansen. 1995. A gene cluster involved in the utilization of both free heme and heme:hemopexin by Haemophilus influenzae type b. J. Bacteriol. 177:2644-2653. |
| 10. | Cope, L. D., S. E. Thomas, Z. Hrkal, and E. J. Hansen. 1998. Binding of heme-hemopexin complexes by soluble HxuA protein allows utilization of this complexed heme by Haemophilus influenzae. Infect. Immun. 66:4511-4516. |
| 11. | Coulton, J. W., and J. C. S. Pang. 1983. Transport of haemin by Haemophilus influenzae type b. Curr. Microbiol. 9:93-98. |
| 12. | Dashper, S. G., A. Hendtlass, N. Slakeski, C. Jackson, K. J. Cross, L. Brownfield, R. Hamilton, I. Barr, and E. C. Reynolds. 2000. Characterization of a novel outer membrane hemin-binding protein of Porphyromonas gingivalis. J. Bacteriol. 182:6456-6462. |